Biohaven Pharmactl Hldg Co - COM (BHVN)

CUSIP: G11196105

Q3 2026 13F Holders as of 30 Sep 2026

Share change
+150,000
SEC-reported price per share
$13.50
Indexed holders
1
Value change
+$2,025,000
Number of buys
1

Security key

G11196105

Report period

Q3 2026

Indexed institutions

1

Top holders

1

Ownership snapshot

Top reported holders of BHVN - Biohaven Pharmactl Hldg Co - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
MONTANOVA CAPITAL, LLC
Disclosed value leader
BlackRock, Inc.
Comparable rows
4/15
Latest evidence
30 Sep 2026
13F 13D/G 3/4/5 Lead comparable stake: 7.8% 11 rows are not safely comparable across share classes. 13D/G row: MONTANOVA CAPITAL, LLC Showing 1-6 of 15 holder rows.

Quick read

MONTANOVA CAPITAL, LLC leads the comparable SEC ownership view at 7.8%.

4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MONTANOVA CAPITAL, LLC's linked filing trail.
Comparable ownership Top 4
MONTANOVA CAPITAL, LLC 7.8%
Woodline Partners LP 5.1%
VANGUARD GROUP INC 2.7%
Janus Henderson Group Ltd. 1.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
MONTANOVA CAPITAL, LLC
13F 13D/G
Company · SUVRETTA CAPITAL MANAGEMENT, LLC
7.8%
Reported 13D/G · 31 Dec 2025
$153,069,623
10,286,937 shares
— 30 Jun 2026
Woodline Partners LP
13D/G 13F
Company
5.1%
Reported 13D/G · 30 Jun 2026
$120,726,013
7,660,280 shares
$0 30 Jun 2026
VANGUARD GROUP INC
13D/G
The Vanguard Group
2.7%
Reported 13D/G · 30 Sep 2025
$43,156,602
2,875,190 shares
$0 30 Sep 2025
Janus Henderson Group Ltd.
13D/G
1.4%
Reported 13D/G · 30 Sep 2026
$27,183,230
2,036,197 shares
-$87,422,195 30 Sep 2026
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$196,573,505
13,210,585 shares
— 30 Jun 2026
STIFEL FINANCIAL CORP
13F
Company
13F
—
denominator unverified
$147,924,530
9,941,165 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
1
Shares
2,502,520
Indexed holders
1
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 indexed holders
1
Q3 2026 indexed holders
1
Indexed holder difference
0
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .